Skip to main content

MEDNAX, Inc. (MD)

NYSE: MD · IEX Real-Time Price · USD
25.27 -0.47 (-1.83%)
Dec 3, 2021 4:00 PM EST - Market closed
Market Cap2.18B
Revenue (ttm)1.83B
Net Income (ttm)19.15M
Shares Out86.45M
EPS (ttm)0.23
PE Ratio109.39
Forward PE13.48
Dividendn/a
Ex-Dividend Daten/a
Volume529,880
Open25.81
Previous Close25.74
Day's Range25.12 - 26.07
52-Week Range20.27 - 35.67
Beta2.09
AnalystsHold
Price Target28.18 (+11.5%)
Earnings DateOct 28, 2021

About MD

MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectan...

IndustryHealth Care Providers & Services
IPO DateSep 19, 1995
Employees5,600
Stock ExchangeNYSE
Ticker SymbolMD
Full Company Profile

Financial Performance

In 2020, MEDNAX's revenue was $1.73 billion, a decrease of -2.57% compared to the previous year's $1.78 billion. Losses were -$796.49 million, -46.82% less than in 2019.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for MEDNAX stock is "Hold." The 12-month stock price forecast is 28.18, which is an increase of 11.52% from the latest price.

Price Target
$28.18
(11.52% upside)
Analyst Consensus: Hold

News

Mednax to Present at Bank of America 2021 Leveraged Finance Conference

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at Bank of America 2021 Leveraged Finance Conference

2 weeks ago - Business Wire

Mednax to Present at Credit Suisse 30th Annual Healthcare Conference

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at Credit Suisse 30th Annual Healthcare Conference

3 weeks ago - Business Wire

MEDNAX's (MD) Q3 Earnings Beat Estimates, Revenues Up Y/Y

MEDNAX's (MD) third-quarter results reflect growing revenues driven by rising patient volumes, partly offset by higher general and administrative expenses.

1 month ago - Zacks Investment Research

Mednax (MD) Q3 Earnings and Revenues Surpass Estimates

Mednax (MD) delivered earnings and revenue surprises of 9.52% and 2.22%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Mednax Reports Third Quarter Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Reports Third Quarter Results

1 month ago - Business Wire

4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes

Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.

1 month ago - Zacks Investment Research

Why Mednax (MD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 month ago - Zacks Investment Research

Mednax (MD) Earnings Expected to Grow: Should You Buy?

Mednax (MD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Mednax 2021 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 28, 2021

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2021 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 28, 2021

1 month ago - Business Wire

NextGen's (NXGN) Integrated Platform Gets Leveraged by Mednax

Mednax utilizes NextGen's (NXGN) fully-integrated platform to enhance its efficacy in placing crucial information on patients' health and well-being at the physician's fingertips.

1 month ago - Zacks Investment Research

Mednax Clinical Leadership Urges Full Vaccination and All Measures to Protect Expecting Mothers and Children During C...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Mednax provides full support of the CDC and other medical associations' recommendations that all eligible Americans be vaccinated against COVID-19.

1 month ago - Business Wire

Mednax (MD) Invests in Brave Care to Boost Pediatric Business

Mednax (MD) and Brave Care form a relationship to provide enhanced pediatric care and pursue its pipeline of pediatric clinics' plan.

1 month ago - Zacks Investment Research

Brave Care, The Leader in Technology-Powered Pediatric Clinics, Raises $25M in Series B Investment led by Mednax, Inc.

PORTLAND, Ore., Oct. 7, 2021 /PRNewswire/ -- Brave Care, the first pediatric healthcare and technology platform dedicated to improving primary and urgent care for children, today announced it has raised...

1 month ago - PRNewsWire

Mednax and Brave Care to Accelerate Transformation of Pediatric Primary and Urgent Care

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Mednax, Inc. and privately owned Brave Care will develop new, innovative pediatric primary and urgent care clinics throughout the United States.

1 month ago - Business Wire

The Pediatrix® and Obstetrix® Medical Group Reports Surge in Critically Ill Pregnant Patients with the COVID-19 Delta...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #COVID19--Pediatrix® and Obstetrix® affiliated clinicians are treating more pregnant women critically ill with COVID-19 than at any point in the pandemic.

1 month ago - Business Wire

Here's Why You Should Retain MEDNAX (MD) in Your Portfolio

Riding high on its revenue stream and strategic measures, MEDNAX (MD) holds potential to reap benefits for investors.

2 months ago - Zacks Investment Research

Mednax to Present at Morgan Stanley 19th Annual Global Healthcare Conference

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at Morgan Stanley 19th Annual Global Healthcare Conference

2 months ago - Business Wire

MEDNAX's (MD) Earnings Beat Estimates in Q2, Improve Y/Y

MEDNAX's (MD) Q2 results reflect solid volumes, partly offset by escalating expenses.

3 months ago - Zacks Investment Research

Mednax (MD) Beats Q2 Earnings and Revenue Estimates

Mednax (MD) delivered earnings and revenue surprises of 24.24% and 3.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Mednax: Q2 Earnings Insights

Shares of Mednax (NYSE:MD) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share rose 28.12% year over year to $0.41, which beat the estimate of $0.32.

3 months ago - Benzinga

Mednax Reports Second Quarter Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Reports Second Quarter Results

3 months ago - Business Wire

Earnings Outlook For Mednax

Mednax (NYSE:MD) releases its next round of earnings this Friday, August 06. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.

3 months ago - Benzinga

Mednax (MD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Down 11.6% in 4 Weeks, Here's Why Mednax (MD) Looks Ripe for a Turnaround

Mednax (MD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnin...

4 months ago - Zacks Investment Research

Mednax 2021 Second Quarter Conference Call/Webcast Scheduled for Friday, August 6, 2021

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2021 Second Quarter Conference Call/Webcast Scheduled for Friday, August 6, 2021

4 months ago - Business Wire